Physician profile
Emile C Li
NPI 1285687418
$24,701.43
in general payments reported to CMS, 2019-2025
12 companies · $3,926 in 2025
The $3,926 reported for 2025 was more than what 78% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,056 · 2020: $6,138 · 2021: $7,464 · 2022: $2,902 · 2023: $18.11 · 2024: $1,198 · 2025: $3,926.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,331 · Food and Beverage: $1,425 · Education: $385.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,330.81 |
| Food and Beverage | $1,425.49 |
| Education | $385.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Maxx Orthopedics, INC. | $8,907.37 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $5,334.32 | 2021-2025 | Oxford, Comprehensive Shoulder System, Persona |
| Wardlow Enterprises | $3,987.85 | 2019-2021 | |
| Arthrex, INC. | $3,566.06 | 2019-2025 | |
| Smith+Nephew, INC. | $1,947.40 | 2019-2025 | Spatial Frame, Novostitch |
| Prism Medical | $640.89 | 2025 | |
| Orthalign INC | $118.58 | 2022 | |
| Exactech, INC. | $90.75 | 2019 | |
| Depuy Synthes Sales INC. | $37.67 | 2025 | Monovisc |
| Vertex Pharmaceuticals Incorporated | $31.10 | 2025 | |
| Pacira Therapeutics, INC. | $21.33 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $18.11 | 2023 | Exparel, Iovera, Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emile Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.